Managing Healthcare Costs: Strategies for Efficient
Resource Allocation
Introduction
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
Rising healthcare costs present one of the greatest economic and social
challenges facing nations worldwide. In the United States, costs are
estimated to grow at an unsustainable 5.5% annually over the next decade if
decisive action is not taken (Martin, et al., 2018). As a share of GDP,
healthcare expenditures are projected to increase from 17.7% in 2015 to
19.7% by 2025, stressing governmental budgets and private household
finances (Martin, et al., 2018). While access to high-quality care is critically
important, unlimited spending growth represents an untenable path that will
crowd out other national priorities if left unaddressed. This paper analyzes
the drivers fueling inefficient resource allocation in American healthcare and
surveys administrative strategies that have shown promise in improving
value through more prudent cost management. Focusing on payment reform,
care delivery transformation, and cost transparency/consumer engagement
tactics, a balanced discussion is provided of approaches that aim to preserve
care quality and access while promoting sustainability. The goal is to outline
a comprehensive framework for healthcare leaders seeking data-driven
solutions to this pressing economic challenge.
Cost Drivers and Inefficiencies
Before examining administrative interventions, it is important to understand
the structural and behavioral factors driving excessive costs in the U.S.
healthcare system. Hospital and outpatient care prices appear comparatively
high across international benchmarks due largely to provider consolidation
driving negotiations far above costs, high administrative overhead related to
billing thousands of payers with dissimilar rules, and prevalent low-value
utilization (Papanicolas, et al., 2018). Additionally, lack of care coordination
leads to duplication and preventable emergency visits when issues acutely
spike versus addressing underlying chronic conditions optimally (Fisher, et
al., 2009).
At a more granular level, studies have identified particular areas where
resources could be reallocated more efficiently. For instance, 30% of total
healthcare spending is estimated as wasteful, providing no benefit to
recipients (Berwick & Hackbarth, 2012). Areas frequently cited include
unnecessary elective procedures, inefficient inpatient preferences,
overtreatment of chronically ill populations, defensive medicine practices,
high prices for pharmaceuticals and medical devices, and preventable
medical errors (Burns & Pauly, 2018). Lifestyle factors such as smoking,
obesity, and substance abuse account for an estimated 40% of direct
medical care costs, exacerbating spending growth given prevalence
increases (Ford, et al., 2008). Another 18% of Medicare's budget goes to care
for the final year of life despite limited clinical benefits (Riley & Lubitz, 2010).
Better managing these facets represents an opportunity to direct saving
towards programs with higher value.
Payment Reforms to Control Costs
Transforming payment arrangements from volume-based to value-based
models has emerged as a leading administrative strategy for optimizing
resource allocation. Rather than rewarding utilization alone, value-based
payments tie reimbursement to care quality and efficiency metrics. This
realigns incentives towards high-priority services delivering the most clinical
benefit per dollar spent. Various payment models have shown promise if
thoughtfully designed (McWilliams, 2016):
Bundled/Episode-Based Payments: Reimbursing providers/systems a set fee
for an entire clinical episode covering all related services delivered during
that period (e.g. joint replacement, heart attack, childbirth). This incentivizes
reductions in unnecessary procedures/tests and coordinating appropriate
post-acute care arrangements. Implementations have demonstrated 5-30%
spending reductions for common episodes.
Accountable Care Organizations (ACOs): Groups of doctors/hospitals jointly
accountable for both quality and total cost of care for a defined patient
population. Shared savings are awarded if quality standards are met and
costs come in below benchmarks, with two-sided risk models holding
providers liable for excess expenditures. Overall Medicare ACO savings have
averaged 1-2%, though top performers achieve 5-15% reductions.
Reference Pricing: Setting a maximum reimbursement level for costly
services/procedures to encourage use of lower-priced, higher-value
providers. Self-insured employers using reference pricing for joint
replacements or colonoscopies have reduced total costs 15-25% without
compromising outcomes.
Pay-for-Performance: Linking a portion of provider compensation directly to
achievement of pre-set quality, process, and efficiency metrics. Meta-
analyses find pay-for-performance modestly but statistically significantly
improves clinical processes without clear effects on costs or health outcomes
to date.
Global Budgets/Population-Based Payments: Prospectively setting an annual
operating budget for a provider group or clinically integrated network
covering all expected healthcare expenses for a defined patient population.
Budget risk-bearing entities have flexibility to allocate funding across care
settings as needed to optimize value. Studies show global budgets can
reduce expenditures 1-5% annually.
By rewarding quality and efficiency over volume, these payment innovations
motivate delivery system changes leading to more prudent resource
allocation over the long run. While scale-up challenges exist, a balanced
primary care-centered system incorporating models like these shows promise
for improving affordability.
Delivery System Transformation
To operate successfully under value-based payment, providers must
comprehensively redesign care delivery models, workflows, staffing, and
infrastructure. Coordinated, patient-centered approaches emphasizing
prevention and primary care can enhance clinical outcomes while reducing
low-value specialist visits, tests, procedures, readmissions, and medical
errors. Effectively managing high-need/high-cost populations through
intensive care coordination also controls total expenditures. Some proven
care transformation tactics include (Martin et al., 2018):
Advanced Primary Care Models: Patient-centered medical homes leverage
technology, team-based care, and data analytics to implement evidence-
based protocols, coordinate care transitions, address social determinants,
and actively manage chronic illness - estimates show savings of 2-5% per-
capita.
Accountable Care: As discussed, ACO structures hold groups jointly
responsible for longitudinal, population-based care across settings. Meta-
analyses find shared savings of 1-2% overall when primary care medical
homes anchor multi-disciplinary ACO teams.
Bundled Payment Care Improvement Initiatives: Requiring condition-specific
pathways, appropriateness criteria, standardized order sets, and appropriate
post-acute arrangements to reduce variation and unnecessary costs
surrounding clinical episodes. Savings estimates range 5-30% depending on
condition.
Telehealth Expansion: Virtual visits for minor issues, remote monitoring of
chronic diseases, e-consultations for specialists all improve access while
potentially preventing costly emergency department use and readmissions
when structured prudently.
Comprehensive Primary Care Plus: Additional PMPM payments support
enhanced services like group visits, same-day appointments, 24/7 access,
and complex/high-risk care management. Early results show 3-5% cost
savings.
The overarching aims are shifting from sickness to wellness, broadening
provider incentives, and giving care teams flexibility to maximize value
through the most efficient longitudinal arrangements. While upfront
investments are required in redesigned infrastructure, supportive
technologies, and organizational change management, these models hold
promise to curb costs if scaled judiciously with quality safeguards. Rewarding
both quality and efficiency will be keys to success.
Cost Transparency and Consumer Engagement
Finally, promoting prudent consumer decision-making represents an
opportunity to enhance value through competitive forces. Expanding price
and quality transparency enables informed choices that reward higher-value
providers. Complementary tactics engaging consumers financially also
motivate cost-conscious selections. Some examples include (Tu & Lauer,
2009; Whaley, et al., 2014):
- Provider Report Cards: Publicly reporting validated quality, patient
experience, and total cost/episode metrics from claims empowers informed
provider comparisons. Meta-analyses find modest but consistent impacts on
price reductions (1-5%) without negatively impacting quality.
- Price Transparency Tools: Enhanced online tools and mobile apps display
out-of-pocket costs for procedures, services, and providers in a consumer-
friendly manner to guide higher-value selections. Self-insured employers see
5-15% savings from price transparency alone.
- High-Deductible Health Plans (HDHPs): When paired with employer
contributions to health savings accounts, HDHPs incentivize consumers to
consider price before accessing care and negotiate directly with providers to
reduce costs. Studies indicate they lower overall medical claims costs 2-5%.
- Reference Pricing: As discussed, setting maximums for common services
and rewarding selections falling under reference amounts harnesses
consumer price-sensitivity to generate savings around 15-25%.
- Shared Decision-Making Tools: Digital decision aids counseling consumers
on major elective procedures using objective quality and cost data help avoid
preference-sensitive, low-value care with estimated savings from 1-30%
depending on condition.
While consumer-directed strategies aim to control demand, robust
safeguards are needed to avoid underutilization of necessary care among
vulnerable populations. Employer "skin in the game" and assistance
navigating the complex system are also important to maximize potential
benefits.
Regulatory Reforms Supporting Cost Control
To fully realize cost management potential, payment and delivery systems
reforms must be complemented by progressive modernization of associated
regulatory frameworks. Some policy adjustments warranting consideration
include:
- Expanding scope of practice laws and direct primary care models to
optimize teams, reduce referrals/handoffs through principles of clinical
integration and longitudinal management.
- Facilitating timely market entry of generic drugs and streamlining pathways
for biosimilars/next-gen technologies to control pharmaceutical price
inflation.
- Standardizing quality measures, interoperability requirements, and data
sharing to reduce reporting burden and administrative tasks crowding out
direct patient care.
- Enhancing antitrust enforcement policy to prevent anti-competitive
behaviors like monopolistic pricing without compromising collaborative
arrangements truly aimed to improve value.
- Exploring public option models, all-payer rate setting authorities, or global
budgetary caps on public programs to counterbalance consolidated private
market leverage inflating prices.
- Modernizing medical liability frameworks to reduce non-clinical costs
associated with defensive practices driving overtreatment and establish
broader channels for learning from errors without blame.
- Tailoring regulations to support effective models without unduly hindering
innovation or customization needed regionally/locally based on unique
population health needs and resources.
Progress on these types of targeted regulatory reforms represents
opportunities for optimizing the environment within which advanced
payment and delivery system changes can manage costs most effectively at
scale over the long run.
Evaluating Progress and Continuous Improvement
Finally, prudently managing healthcare costs requires ongoing performance
evaluation, feedback loops, and refinement of strategies proven most
impactful. To further learning and advancement:
- Standardized quality metrics, cost benchmarks, patient experience surveys
and administrative data collections enable rigorous program evaluations
conducted independently of vested stakeholders via nonpartisan public
institutions.
- Regional registries and longitudinally-linked databases facilitate continuous
monitoring of utilization, outcomes, expenditures for specific patient cohorts
treated under different payment/delivery models to identify highest value
systems warranting replication.
- "Rounds" programs engage mutli-disciplinary systems across sectors to
voluntarily share discoveries, lessons and modifications through collaborative
improvement networks aiming to advance the field more rapidly than any
single entity alone.
- Public reporting and transparent sharing of both positive and negative
results holds all participants accountable while encouraging emulation of
evidence-based tactics shown to yield optimal returns on resource
investments.
- Staged pilots and phased rollouts, with waiver authority as needed for
promising novel models still maturing, balance innovation against risk as
changes are made implementable at scale based on actionable evaluation
findings.
Ongoing, well-funded evaluation serves to validate prudent resource
allocation, redirect investments to superior approaches, fill evidence gaps,
and support continuous refining of interventions to sustainably bend the cost
curve over the long trajectory. This type of non-linear progress monitoring
will prove crucial to containing unsustainable spending growth.
Conclusion
Effectively stewarding finite healthcare resources represents both an
economic and moral imperative. While the United States has made progress
in expanding access to high-quality care, status quo cost projections portend
significant strains to household budgets, business competitiveness, and
other public priorities if left unaddressed. This paper surveyed a
comprehensive framework for healthcare administrators seeking
management strategies emphasizing value, evidence, and long-term
sustainability. Payment reform, care delivery transformation, cost
transparency, and complementary regulatory modernization offer prudent,
balanced options for optimizing healthcare spending when tailored
judiciously to unique population needs and piloted through well-designed
pilots and evaluation protocols. Ongoing monitoring and continuous
improvement will further strengthen the impact over time. With multi-
stakeholder commitment and databased progress tracking, a high-
performing system optimizing outcomes affordably remains achievable.
